CYTOKINETICS INC
CYTK
80 insider filings · Latest: Aug 10, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | Apr 15 9:27 PM | Robert I BlumDirector, President & CEO | Sale | 7,500 | $65.38 | $490.3K | 415,330(D) | View → |
| Apr 15, 2026 | Apr 15 8:55 PM | ANDREW CALLOS | Proposed Sale | 79,639 | $66.35 | $5.3M | — | View → |
| Apr 7, 2026 | Apr 8 8:18 PM | Fady Ibraham MalikEVP Research & Development | Sale | 4,500 | $65.11 | $293.0K | 153,902(D) | View → |
| Apr 7, 2026 | Apr 7 8:26 PM | FADY MALIK | Proposed Sale | 22,000 | $64.94 | $1.4M | — | View → |
| Apr 1, 2026 | Apr 1 8:47 PM | ROBERT BLUM | Proposed Sale | 45,000 | $65.91 | $3.0M | — | View → |
| Apr 1, 2026 | Apr 1 8:34 PM | Robert I BlumDirector, President & CEO | Sale | 7,500 | $66.63 | $499.7K | 422,830(D) | View → |
| Mar 31, 2026 | Mar 31 8:24 PM | ANDREW CALLOS | Proposed Sale | 3,639 | $62.97 | $229.1K | — | View → |
| Mar 31, 2026 | Mar 31 8:21 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 3,639 | $65.00 | $236.5K | 66,004(D) | View → |
| Mar 17, 2026 | Mar 18 9:46 PM | Sung LeeEVP, Chief Financial Officer | Sale | 4,935 | $62.15 | $306.7K | 87,127(D) | View → |
| Mar 17, 2026 | Mar 18 9:43 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 8,542 | $62.15 | $530.9K | 71,573(D) | View → |
| Mar 17, 2026 | Mar 18 9:40 PM | Fady Ibraham MalikEVP Research & Development | Sale | 12,033 | $62.15 | $747.9K | 153,902(D) | View → |
| Mar 17, 2026 | Mar 18 9:37 PM | Robert I BlumDirector, President & CEO | Sale | 36,601 | $62.15 | $2.3M | 430,330(D) | View → |
| Mar 18, 2026 | Mar 18 8:55 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 1,930 | $62.07 | $119.8K | 78,185(D) | View → |
| Mar 18, 2026 | Mar 18 8:31 PM | ANDREW CALLOS | Proposed Sale | 1,930 | $62.13 | $119.9K | — | View → |
| Mar 16, 2026 | Mar 16 9:14 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 1,709 | $61.03 | $104.3K | 46,149(D) | View → |
| Mar 16, 2026 | Mar 16 8:39 PM | ANDREW CALLOS | Proposed Sale | 1,709 | $60.06 | $102.6K | — | View → |
| Mar 9, 2026 | Mar 10 10:05 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 2,582 | $60.72 | $156.8K | 47,858(D) | View → |
| Mar 9, 2026 | Mar 10 10:03 PM | Fady Ibraham MalikEVP Research & Development | Sale | 2,907 | $60.72 | $176.5K | 138,629(D) | View → |
| Mar 9, 2026 | Mar 10 10:00 PM | Robert I BlumDirector, President & CEO | Sale | 7,931 | $60.72 | $481.6K | 391,673(D) | View → |
| Mar 5, 2026 | Mar 5 9:27 PM | Andrew CallosEVP, Chief Commercial Officer | Sale | 26,000 | $61.87 | $1.6M | 50,440(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Aug 10 9:11 PM | Robert I BlumDirector, President & CEO | Option Exercise | 7,500 | $10.60 | 171,745(D) | View → |
| Jul 30, 2026 | Jul 30 8:26 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 14,000 | $23.26 | 10,000(D) | View → |
| Jul 27, 2026 | Jul 27 8:33 PM | Robert I BlumDirector, President & CEO | Option Exercise | 7,500 | $10.60 | 179,245(D) | View → |
| Jul 21, 2026 | Jul 23 8:09 PM | Fady Ibraham MalikEVP Research & Development | Option Exercise | 3,500 | $7.80 | 33,886(D) | View → |
| Jul 13, 2026 | Jul 14 7:34 PM | Robert I BlumDirector, President & CEO | Option Exercise | 7,490 | $10.60 | 186,745(D) | View → |
| Jul 7, 2026 | Jul 7 9:06 PM | Fady Ibraham MalikEVP Research & Development | Option Exercise | 3,500 | $7.80 | 37,386(D) | View → |
| Jul 1, 2026 | Jul 2 9:19 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 15,000 | $23.26 | 24,000(D) | View → |
| Jul 1, 2026 | Jul 2 9:17 PM | Sung LeeEVP, Chief Financial Officer | Option Exercise | 1,112 | $48.51 | 26,709(D) | View → |
| Jun 24, 2026 | Jun 29 10:05 PM | Sung LeeEVP, Chief Financial Officer | Option Exercise | 38,730 | $48.51 | 27,821(D) | View → |
| Jun 29, 2026 | Jun 29 9:23 PM | Sung LeeEVP, Chief Financial Officer | Option Exercise | 3,134 | $48.51 | 39,681(D) | View → |
| Jun 23, 2026 | Jun 23 9:41 PM | Fady Ibraham MalikEVP Research & Development | Option Exercise | 3,500 | $7.80 | 40,886(D) | View → |
| Jun 9, 2026 | Jun 9 9:40 PM | Fady Ibraham MalikEVP Research & Development | Option Exercise | 3,500 | $7.80 | 44,386(D) | View → |
| Jun 1, 2026 | Jun 1 10:51 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 15,000 | $23.26 | 39,000(D) | View → |
| May 27, 2026 | May 27 11:16 PM | Muna BhanjiDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
| May 27, 2026 | May 27 11:14 PM | James M DalyDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
| May 27, 2026 | May 27 11:13 PM | Robert Arthur HarringtonDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
| May 27, 2026 | May 27 11:12 PM | John T HendersonDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
| May 27, 2026 | May 27 11:11 PM | Edward M. Kaye MDDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
| May 27, 2026 | May 27 11:10 PM | Lynne B ParshallDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
| May 27, 2026 | May 27 11:09 PM | Robert E LandryDirector | Grant/Award | 4,301 | $77.15 | 4,301(D) | View → |
Page 1 of 2
Next →